KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Share-based Compensation (2021 - 2025)

Historic Share-based Compensation for QuidelOrtho (QDEL) over the last 5 years, with Q3 2025 value amounting to $10.7 million.

  • QuidelOrtho's Share-based Compensation fell 1300.81% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.7 million, marking a year-over-year decrease of 22.32%. This contributed to the annual value of $42.1 million for FY2024, which is 1841.09% down from last year.
  • According to the latest figures from Q3 2025, QuidelOrtho's Share-based Compensation is $10.7 million, which was down 1300.81% from $12.8 million recorded in Q2 2025.
  • QuidelOrtho's 5-year Share-based Compensation high stood at $29.7 million for Q1 2023, and its period low was $7.0 million during Q4 2021.
  • For the 5-year period, QuidelOrtho's Share-based Compensation averaged around $12.4 million, with its median value being $11.4 million (2024).
  • The largest annual percentage gain for QuidelOrtho's Share-based Compensation in the last 5 years was 4864.86% (2023), contrasted with its biggest fall of 5858.59% (2023).
  • Quarter analysis of 5 years shows QuidelOrtho's Share-based Compensation stood at $7.0 million in 2021, then grew by 5.71% to $7.4 million in 2022, then soared by 66.22% to $12.3 million in 2023, then dropped by 21.95% to $9.6 million in 2024, then rose by 11.46% to $10.7 million in 2025.
  • Its Share-based Compensation was $10.7 million in Q3 2025, compared to $12.8 million in Q2 2025 and $11.6 million in Q1 2025.